81
TITLE: Sodium butyrate reduces 18F-FDG uptake in two colon cancer cell lines  Full Text
AUTHORS: Goncalves, TJ; Pires, AS ; Encamacao, JC; Marques, CR; Casalta Lopes, JE; Tralhao, JG; Abrantes, AM ; Maria Filomena Botelho ;
PUBLISHED: 2013, SOURCE: Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, VOLUME: 40
INDEXED IN: WOS
82
TITLE: 18F-FDG: WHAT IS ITS ROLE IN PROSTATE CANCER?
AUTHORS: Pedrosa, L; Mamede, AC; Abrantes, AM ; Pires, AS ; Teixo, RJ; Ana Cristina Gonçalves ; Sarmento Ribeiro, AB; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 10th International Symposium on Targeted Anticancer Therapies in ANNALS OF ONCOLOGY, VOLUME: 23
INDEXED IN: WOS
83
TITLE: AN IN VIVO STUDY TO ANALYSE THE POTENTIAL OF 188RE-PEI-MP FOR METABOLIC RADIOTHERAPY OF BLADDER CARCINOMA
AUTHORS: Ferreira, S; Laranjo, Mafalda ; Abrantes, AM ; Brito, A; Pires, AS ; Metello, LF; Zeevaart, J; Louw, W; Dormehl, I; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 10th International Symposium on Targeted Anticancer Therapies in ANNALS OF ONCOLOGY, VOLUME: 23
INDEXED IN: WOS Handle
84
TITLE: ANTI-PROLIFERATIVE EFFECT OF CISPLATIN, DOXORUBICIN AND EPIRUBICIN IN TWO PROSTATE CANCER CELL LINES
AUTHORS: Mamede, AC; Abrantes, AM ; Pedrosa, L; Pires, AS ; Maia, CJ ; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 10th International Symposium on Targeted Anticancer Therapies in ANNALS OF ONCOLOGY, VOLUME: 23
INDEXED IN: WOS
85
TITLE: Ascorbic Acid Effect in Two Different Cell Lines of Colorectal Adenocarcinoma - in Vitro and in Vivo Studies  Full Text
AUTHORS: Pires, AS ; Mamede, AC; Silva, VS; Abrantes, AM ; Ana Cristina Gonçalves ; Sarmento Ribeiro, AB; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 22nd Biennial Congress of the European-Association-for-Cancer-Research in EUROPEAN JOURNAL OF CANCER, VOLUME: 48
INDEXED IN: WOS CrossRef
87
TITLE: EFFECT OF alpha-TOCOFERIL SUCCINATE IN TWO DIFFERENT CELL LINES OF COLORECTAL ADENOCARCINOMA
AUTHORS: Vanessa Silva; Ana Pires ; Ana Abrantes ; Ana Brito; Ana Goncalves; Ana Sarmento Ribeiro; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 23
INDEXED IN: WOS
88
TITLE: Old and new radiopharmaceuticals for PET: what is the role of 18F-FDG and 18F-CHO in prostate cancer?  Full Text
AUTHORS: Pedrosa, L; Abrantes, AM ; Mamede, AC; Teixo, RJ; Pires, AS ; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, VOLUME: 39
INDEXED IN: WOS
89
TITLE: Prostate Cancer - What Happens Beyond the Limits of Oxygen?  Full Text
AUTHORS: Pedrosa, L; Abrantes, AM ; Mamede, AC; Pires, AS ; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 22nd Biennial Congress of the European-Association-for-Cancer-Research in EUROPEAN JOURNAL OF CANCER, VOLUME: 48
INDEXED IN: WOS CrossRef
90
TITLE: Radiolabelling of ascorbic acid: A new clue to clarify its action as an anticancer agent?
AUTHORS: Mamede, AC; Abrantes, AM ; Pires, AS ; Tavares, SD; Serra, ME ; Maia, JM; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: Current Radiopharmaceuticals, VOLUME: 5, ISSUE: 2
INDEXED IN: Scopus CrossRef: 3
Page 9 of 10. Total results: 96.